Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Debt Ratio (2017 - 2025)

Serina Therapeutics' Debt Ratio history spans 9 years, with the latest figure at 0.23 for Q3 2025.

  • For Q3 2025, Debt Ratio changed N/A year-over-year to 0.23; the TTM value through Sep 2025 reached 0.23, changed N/A, while the annual FY2022 figure was 5.59, 187.63% up from the prior year.
  • Debt Ratio for Q3 2025 was 0.23 at Serina Therapeutics, down from 1.04 in the prior quarter.
  • Across five years, Debt Ratio topped out at 5.59 in Q4 2022 and bottomed at 0.18 in Q3 2023.
  • The 5-year median for Debt Ratio is 2.54 (2023), against an average of 2.8.
  • The largest annual shift saw Debt Ratio surged 570.64% in 2021 before it crashed 95.66% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 1.94 in 2021, then surged by 187.63% to 5.59 in 2022, then crashed by 96.75% to 0.18 in 2023, then surged by 472.34% to 1.04 in 2024, then tumbled by 77.63% to 0.23 in 2025.
  • Per Business Quant, the three most recent readings for SER's Debt Ratio are 0.23 (Q3 2025), 1.04 (Q2 2024), and 0.96 (Q1 2024).